Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00328_DB00682_nanopub.RA0h5E0sN6FqI7Ux3BGa7uxRH5fvoLfch00OcjcteCFd8#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00328_DB00682 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00328_DB00682 label "DDI between Indomethacin and Warfarin - Indomethacin, a strong CYP2C9 inhibitor, may decrease the metabolism of warfarin. The antiplatelet effect of indomethacin may also increase the bleed risk associated with warfarin. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of warfarin if indomethacin is initiated, discontinued or dose changed. [drugbank_resource:DB00328_DB00682]" assertion.
- drugbank_resource:DB00328_DB00682 identifier "drugbank_resource:DB00328_DB00682" assertion.
- drugbank_resource:DB00328_DB00682 title "DDI between Indomethacin and Warfarin - Indomethacin, a strong CYP2C9 inhibitor, may decrease the metabolism of warfarin. The antiplatelet effect of indomethacin may also increase the bleed risk associated with warfarin. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of warfarin if indomethacin is initiated, discontinued or dose changed." assertion.
- drugbank:DB00682 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00328_DB00682 assertion.
- drugbank:DB00328 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00328_DB00682 assertion.